Vancouver Diabetes Research Day 2024
Our 11th Annual Vancouver Diabetes Research Day (VDRD) was held on November 14, 2024 to mark the World Health Organization recognition of World Diabetes Day 2024. The event was held on the University of British Columbia campus in Vancouver at the UBC Alumni Centre and the Life Sciences Institute.
Our annual academic scientific day is aimed at inter provincial engagement. The event included researchers from across both UBC Vancouver and UBC Okanagan campuses, Simon Fraser University and the University of Northern British Columbia. VDRD 2024 was our largest research day and attracted 158 delegates and included 14 oral trainee presentations and 40 poster presentations and 2 invited faculty presentations.
We are grateful to our Keynote Speaker Dr Anna Gloyn, D Phil from Stanford University and Invited Speaker Jeeyeon Cha, MD, PhD from Vanderbilt University.
Congratulations to our VDRD 2025 People’s Choice Awardees:
Sing-Young Chen, PhD, Life Sciences Institute, UBC
Understanding sex differences in beta-cell resilience to endoplasmic reticulum stress
Sean A. Fox, BC Children’s Hospital Research Institute, UBC
Enhancing SC-β cell function in type 1 diabetes through co-culture with M2-Polarized macrophages
Ekaterina Filatov, BC Children’s Hospital Research Institute, UBC
Improving CCL22-induced Treg migration to stem cell-derived islets
Simran Gill, UBC Okanagan
Navigating challenges: Exploring barriers and facilitators to physical activity in children with type 1 diabetes
Liam Hall, PhD Life Sciences Institute, UBC
Metabolic consequences of physical inactivity
Moses Jeong, Simon Fraser University
Kinetic modelling of leucine-mediated signalling and protein synthesis in insulin-resistant human skeletal muscle
Samantha Mar, BC Children’s Hospital Research Institute, UBC
Master gene regulator Med15 is required for regulating fasting blood glucose levels in adult male mice
Jakob Ostberg, University of Northern British Columbia
Improving insulin sensitivity in obesity through targeted delivery of anti-diabetic drugs to adipose tissue using magnetic nanoparticles
Lindsay P. Pallo, BC Children’s Hospital Research Institute
An mRNA-lipid nanoparticle vaccine protects against and reverses type 1 diabetes via Treg induction and effector T-cell dysfunction
Vancouver Diabetes Research Day 2024 demonstrated British Columbia is home to a diverse research community that is passionate about improving the lives of those living with diabetes in Canada and beyond.
